- Private Equity Bros
- Posts
- Private Equity Bros Weekly
Private Equity Bros Weekly
Instantly download thousands of PE/VC contacts – partners, MDs and senior investors – in one dataset you can use for sourcing, fundraising and BD.
📊 Weekly Summary
Highlights from the week in global markets and finance:
A major antitrust lawsuit hit Apollo, Ares, and BlackRock over alleged collusion in the credit markets. The ECB opened a probe into Deutsche Bank over potential understatement of balance sheet risks, and global equity funds saw their first outflow in 10 weeks. Markets also absorbed volatility from a CME derivatives outage.
BlackRock moved to deepen its Saudi footprint as the global fund-management industry heads toward a projected $200T in AUM by 2030. India surprised with 8.2% YoY GDP growth. With tech momentum building and regional capital flows improving, Asia once again sat at the center of the market narrative.
Let’s dive in.
📈 Recent Finance News
Apollo, Ares & BlackRock sued over alleged credit-market cartel: A major antitrust lawsuit claims the firms colluded to block a borrower from refinancing (RT)
Global fund managements projected to hit $200T AUM by 2030: The growth will be driven by private markets, passive funds, Asia-Pacific expansion (PwC)
ECB investigates Deutsche Bank over possible understatement of balance-sheet risks: Based on claims by a former Deutsche Bank employee (YF)
Global equity funds see first weekly outflow in 10 weeks: Investors pulled $4.48B amid stretched valuations and macro uncertainty (RT)
Global bond markets under growing stress from hedge-fund leverage: Heavy non-bank leverage in sovereign bond markets poses systemic risk (MC)
BlackRock targets doubling Saudi investments amid deal boom: The asset manager deepens exposure to Gulf-region opportunities (PEI)
AI-linked tech stocks extend global rebound, lifting broader equity markets across Asia: Tech & AI themes continue to drive market optimism (SAXO)
India’s economy grew 8.2% YoY in Q3, beating forecasts: Underscores India’s resilience amid global headwinds and may draw further global capital inflows (TOI)
Global markets shaken by CME derivatives outage: Temporary disruption in a major derivatives platform triggered sharp moves (AInvest)
Asian shares rebound as Fed-cut bets rise: Asian markets rose as investor optimism about potential US rate cuts boosted risk sentiment (ABC)
Stop wondering how to build the perfect deck - directly access 400 IB decks from 150+ closed deals advised by the world’s top banks.
🔍 Newly Released Reports
Leveraging Space Investments to Drive Growth (KPMG)
Asset & Wealth Management Revolution 2025 (PwC)
7 Market Dislocations Too Big to Overlook (WT)
Equity Capital Markets Report FY-25 (Ashurst)
Global Private Company Outlook (KPMG)
GCC Wealth Management Report (EY)
European M&A Outlook 2026 (CMS)
A New Lens on Private Credit (MSCI)
Secondaries in the Spotlight (CVC)
Global Market Outlook (HSBC)
2026 Bank M&A Survey (Crowe)
📈 The go-to resource pack trusted by top finance professionals
🤝 M&A Activity
Merck & Co. to acquire biotech company Cidara Therapeutics (CNBC)
Deal Value: $9.2B
Mining giant Lukoil buys co-founder Leonid Fedun's stake (MT)
Potential Deal Value: $7B
Veolia to acquire US hazardous-waste specialist Clean Earth (LR)
Deal Value: $3B
Lone Star, Altaris, One Rock eye Lonza capsules & health ingredients unit (PEW)
Potential Deal Value: $2.5B
EQT Future buys majority stake in DESOTEC from Blackstone (PRN)
Deal Value: $2.3B
Spanish renewable energy firm Iberdrola eyes takeover of Brazilian affiliate (Inv.)
Deal Value: $1.2B
UK media firm Daily Mail & General Trust to acquire Telegraph Media Group (YF)
Deal Value: $655M
TPG and Warburg Pincus in talks to buy stake in software firm Sirion (PEW)
Potential Deal Value: $500M
Japan Hotel REIT acquires Hyatt Regency Tokyo from KKR and Gaw Capital (MT)
Deal Value: Undisclosed
Singapore’s DBS to acquire 30% stake in Alliance Bank Malaysia (YF)
Deal Value: Undisclosed
That wraps up this week’s insights. More coming your way next week.
PE Bro
📚 Unlock Private Equity Elite Programmes
Rosé Can Have More Sugar Than Donuts?
No wonder 38% of adults prefer health-conscious beverages. AMASS Brands is raking in sales by tapping into this trend. They’ve earned $80M+, including 1,000% year-over-year
growth, thanks to products like their top-selling zero-sugar rosé. They even reserved the Nasdaq ticker $AMSS. Join celebs like Adam Levine and Derek Jeter as an AMASS investor and get up to 23% bonus shares today.
This is a paid advertisement for AMASS’s Regulation CF offering. Please read the offering circular at https://invest.amassbrands.com


